Literature DB >> 7389537

Hyperglobulinemia in alcoholic cirrhosis. Relationship with portal hypertension and intrahepatic portal-systemic shunting as assessed by Kupffer cell uptake.

G Pomier-Layrargues, P M Huet, G Richer, D Marleau, A Viallet.   

Abstract

The relative importance of portal hypertension and intrahepatic portal-systemic shunting in the pathogenesis of hyperglobulinemia is examined in 31 alcoholic cirrhotic patients and 6 patients with idiopathic portal hypertension. The degree of portal hypertension was evaluated by combined umbilicoportal and hepatic vein catheterization and the intrahepatic portal-systemic hunting was assessed by the Kupffer uptake of [125I]albumin microaggregates during a single passage through the liver. All patients had comparable severe portal hypertension and most had bled from ruptured varices; however, no demonstrable relationship could be found between portal hypertension and hyperglobulinemia. Elevated levels of serum gammaglobulins and immunoglobulins (mainly IgG) were observed only in cirrhotic patients, particularly those with markedly altered Kupffer cell uptake. It is concluded that intrahepatic portal systemic shunting as evaluated by the Kupffer cell uptake is more important than the collateral circulation secondary to portal hypertension in the pathogenesis of hyperglobulinemia in alcoholic cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389537     DOI: 10.1007/bf01315210

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

3.  Vascular pattern of the cirrhotic liver.

Authors:  H POPPER; H ELIAS; D E PETTY
Journal:  Am J Clin Pathol       Date:  1952-08       Impact factor: 2.493

4.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

5.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Immunoglobulins in viral hepatitis and active alcoholic liver-disease.

Authors:  F I Lee
Journal:  Lancet       Date:  1965-11-20       Impact factor: 79.321

8.  Extraction of 125I-albumin microaggregates from portal blood. An index of functional portal blood supply in cirrhotics.

Authors:  P M Huet; D Marleau; P Lavoie; A Viallet
Journal:  Gastroenterology       Date:  1976-01       Impact factor: 22.682

9.  The effects of portacaval shunting and portacaval transposition on serun IgG levels in the rat.

Authors:  I S Benjamin; C J Ryan; A L McLay; C H Horne; L H Blumgart
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

10.  Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure, and E. coli antibodies.

Authors:  D R Triger; T D Boyer; A G Redeker; T B Reynolds; A D Waxman
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

View more
  4 in total

1.  Effect of isolated portal hypertension on Kupffer cell function.

Authors:  M H Basista; R E Stauber; D H Van Thiel; W N Tauxe; V J Dindzans
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

2.  Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction.

Authors:  P A Drew; P M Clifton; J T LaBrooy; D J Shearman
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

3.  IgA in alcoholic cirrhosis.

Authors:  J Kalsi; D L Delacroix; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

4.  Demonstration of non-specific B-cell stimulation in patients with cirrhosis.

Authors:  G Holdstock; W B Ershler; E L Krawitt
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.